EVOKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:32):

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases...

Stats
本日の出来高	24 204.00
平均出来高	40 087.00
時価総額	3.82M
EPS	$-0.590 ( 2024-03-14 )
次の収益日	( $-0.210 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.190
ATR14	$0.00800 (1.78%)

Insider Trading

Date	Person	Action	Amount	type
2023-05-10	Widder Kenneth J	Buy	14 250	Stock Option (Right to Buy)
2023-05-10	Reed Vickie S	Buy	15 000	Stock Option (Right to Buy)
2023-05-10	Hill Malcolm R	Buy	14 625	Stock Option (Right to Buy)
2023-05-10	Garner Cam L	Buy	17 750	Stock Option (Right to Buy)
2023-05-10	Brady Todd C	Buy	14 625	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 99 transactions
Buy: 6 847 814 \| Sell: 1 253 905

Evoke Pharma Inc 相関

10 最も正の相関
BGNE	0.878
BNIXU	0.865
FEM	0.853
IMAB	0.852
BLZE	0.847
CLDX	0.845
VRDN	0.843
DADA	0.833
EFAS	0.831
COLL	0.827

10 最も負の相関
RMRM	-0.957
PMD	-0.885
GAINL	-0.869
XPER	-0.858
NEXI	-0.853
RIBT	-0.851
SNCR	-0.85
LEDS	-0.845
TCRX	-0.845
FIZZ	-0.836

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Evoke Pharma Inc 財務諸表

Annual	2023
収益:	$5.18M
総利益:	$4.98M (96.10 %)
EPS:	$-2.33

FY	2023
収益:	$5.18M
総利益:	$4.98M (96.10 %)
EPS:	$-2.33

FY	2022
収益:	$2.51M
総利益:	$2.14M (85.24 %)
EPS:	$-2.60

FY	2021
収益:	$1.62M
総利益:	$1.29M (79.72 %)
EPS:	$-3.24

Financial Reports:

No articles found.

Evoke Pharma Inc

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.